Last reviewed · How we verify
MVA-NSmut
At a glance
| Generic name | MVA-NSmut |
|---|---|
| Sponsor | ReiThera Srl |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Staged Phase I/II Hepatitis C Prophylactic Vaccine (PHASE1, PHASE2)
- A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination (PHASE1)
- A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals (PHASE1)
- Study of a New MVA Vaccine for Hepatitis C Virus (PHASE1)
- Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |